Packaging Solutions for Pharmaceuticals & Medical Devices: Insights and Considerations
XTalks
MAY 13, 2022
E&L testing is performed to substantiate that packaging materials will not contaminate the drug product over a product’s shelf life. If they do, the FDA will assume the worst-case scenario and deem the compound or fragment to be genotoxic or eugenic. These compounds thus become a part of the drug matrix. > umbrella).
98 
Let's personalize your content